Brief: Genovis Says Start Of Q3 Continues To Show Good Customer Activity

Genovis AB

24/08/2023 07:44

Aug 24 (Reuters) - Genovis AB  GENOb.ST :
    * WE SEE A CONTINUATION OF STRONG DEVELOPMENT IN US AND
EUROPE
    * ASIA REMAINS WEAKER DUE TO GENERALLY SUBDUED CUSTOMER
ACTIVITY
IN CHINA
    * WE HAVE GOOD ACTIVITY IN OUR BUSINESS AND DEMAND IS WIDELY
DISTRIBUTED ACROSS OUR GROWING PRODUCT PORTFOLIO
    * WE PERCEIVE A GRADUAL INCREASE IN FOCUS ON INFLAMMATION
AND
IMMUNOLOGICAL DISEASES IN PHARMACEUTICAL INDUSTRY
    * WE SEE AN INCREASE IN INVESTMENTS IN NEXT-GENERATION MRNA
TECHNOLOGIES AND NOTE THAT OUR PRODUCTS ARE BEING USED AND
EVALUATED IN SEVERAL MRNA PROJECTS
    * START OF Q3 CONTINUES TO SHOW GOOD CUSTOMER ACTIVITY
    * WE ARE ALSO MAINTAINING A STRONG CASH POSITION THAT
PROVIDES
OPPORTUNITIES FOR FURTHER AGGRESSIVE INVESTMENTS

Source text for Eikon:  ID:nWkr8HxPF4 
Further company coverage:  GENOb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))